ArticleBMC pregnancy and childbirth2026
Pregnancy characteristics in patients with autoimmune diseases with different onset times and their relationship with pregnancy outcomes.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAutoimmune diseases (AIDs) are highly prevalent among women of reproductive age and are associated with increased risks of adverse pregnancy outcomes (APOs). However, the correlation between different onset times of the diseases and pregnancy outcomes remains unclear. This study aimed to systematically analyze and compare the pregnancy characteristics and outcomes among women with AID, specifically focusing on those whose conditions manifest in childhood, before pregnancy in adulthood, or during pregnancy in adulthood.
methodsA total of 348 pregnant women with AID from 2010 to 2024 were analyzed retrospectively. Patients were categorized based on three different onset times. Clinical features, laboratory characteristics and pregnancy outcomes were compared among groups. Logistic regression analyses were used to explore the relationship between the onset time of AIDs and APOs.
resultsAmong the 348 pregnant patients, 39(11.2%) were childhood-onset cases, 215(61.8%) were cases diagnosed in adulthood before pregnancy and 94(27.0%) were occurring during pregnancy. Compared to pregnancy-onset group, pre-pregnancy-onset group showed a lower risk of fetal loss (OR = 0.410, 95% CI 0.201–0.835, P = 0.014).
conclusionsAn increase in the incidence of adverse pregnancy outcomes was not observed in pregnant patients with autoimmune diseases as disease duration increased. Patients with AID onset during pregnancy in adulthood exhibited more aggressive disease manifestations and demonstrated a significantly higher incidence of APOs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.